Retour
Fourchette du Jour
4,14 €
4,50 €
Fourchette 52 Semaines
2,28 €
4,59 €
Volume
600
Moyenne 50J / 200J
4,44 €
/
3,49 €
Clôture Précédente
4,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,4 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -1251,1 | 3,8 |
| Rev Growth 5Y % | 150,8 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
-0,11 €
-0,11 € – -0,11 €
|
260 M | 4 |
| FY2028 |
-0,55 €
-0,55 € – -0,55 €
|
96 M | 3 |
| FY2027 |
-0,67 €
-0,67 € – -0,67 €
|
25 M | 2 |
Points Clés
Revenue grew 150,82% annually over 5 years — strong growth
Negative free cash flow of -86,26M
Revenue growth is decelerating — 1Y growth trails 5Y average by 166,57%
Capital efficient — spends only 2,26% of revenue on capex
Croissance
Revenue Growth (5Y)
150,82%
Revenue (1Y)-15,75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net Margin-1251,10%
Op. Margin-662,58%
Sécurité
Debt / Equity
N/A
Current Ratio0,92
Interest Coverage-8,01
Valorisation
P/E Ratio
-3,35
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -15,75% | Revenue Growth (3Y) | 9,95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 150,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14,72M | Net Income (TTM) | -184,21M |
| ROE | N/A | ROA | -154,84% |
| Gross Margin | 62,47% | Operating Margin | -662,58% |
| Net Margin | -1251,10% | Free Cash Flow (TTM) | -86,26M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,92 |
| Interest Coverage | -8,01 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,35 | P/B Ratio | N/A |
| P/S Ratio | 41,93 | PEG Ratio | -0,04 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 617,43M | Enterprise Value | 575,20M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 14,72M | 17,48M | 12,18M | 4,19M | 372 000,0 |
| Net Income | -184,21M | -110,43M | -54,27M | -49,64M | -31,62M |
| EPS (Diluted) | -3,08 | -2,43 | -1,31 | -1,27 | -0,93 |
| Gross Profit | 9,20M | 17,50M | 11,18M | 3,18M | -474 000,0 |
| Operating Income | -97,56M | -102,71M | -57,11M | -52,11M | -29,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 118,97M | 69,56M | 116,00M | 121,99M | 138,92M |
| Total Liabilities | 225,61M | 101,59M | 70,53M | 33,12M | 27,71M |
| Shareholders' Equity | -106,65M | -32,03M | 45,48M | 88,87M | 111,21M |
| Total Debt | 54,33M | 37,49M | 34,51M | 10,12M | 13,25M |
| Cash & Equivalents | 96,56M | 26,92M | 86,74M | 86,55M | 105,69M |
| Current Assets | 111,51M | 48,19M | 106,38M | 115,58M | 133,00M |
| Current Liabilities | 120,73M | 50,16M | 30,70M | 22,85M | 13,91M |